Zota Health Care Limited
NSE: ZOTA
Prev Close
1279.2
Open Price
1280
Volume
33,784
Today Low / High
1257.3 / 1292.9
52 WK Low / High
535 / 1397.3
Range
1,206 - 1,333
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 1269.7, with a change of -9.5 (-0.74265%). The expected target range on the NSE is between 1,206 - 1,333. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
Zota Health Care Limited Graph
Zota Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Zota Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,269.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,269.70 | 1,282.40 | 1,154.16 - 1,410.64 |
| 1,295.09 | 1,036.08 - 1,554.11 | ||
| 1,307.79 | 915.45 - 1,700.13 | ||
| Bearish Scenario | 1,269.70 | 1,257.00 | 1,131.30 - 1,382.70 |
| 1,244.31 | 995.44 - 1,493.17 | ||
| 1,231.61 | 862.13 - 1,601.09 |
Overview of Zota Health Care Limited
ISIN
INE358U01012
Industry
Biotechnology
Vol.Avg
106,318
Market Cap
38,227,365,780
Last Dividend
1
Official Website
IPO Date
2017-05-10
DCF Diff
1,260.94
DCF
-301
Financial Ratios Every Investor Needs
Stock Dividend of ZOTA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-20 | September 20, 24 | 1 | 1 | 2024-09-21 | 2024-10-28 | |
| 2023-09-22 | September 22, 23 | 1 | 1 | 2023-09-22 | 2023-10-29 | |
| 2022-09-19 | September 19, 22 | 1.5 | 1.5 | 2022-09-20 | 2022-10-27 | |
| 2021-09-22 | September 22, 21 | 1 | 1 | 2021-09-23 | 2021-10-30 | |
| 2020-09-17 | September 17, 20 | 1 | 1 | 2020-09-18 | 2020-10-26 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 292.97 Cr | 137.30 Cr | 155.67 Cr | 0.5313 | 0.00 Cr | 0.00 Cr | -48.93 Cr | -56.40 Cr | -20.53 | -3.66 Cr | -0.1925 |
| 2024-03-31 | 180.49 Cr | 100.15 Cr | 80.34 Cr | 0.4451 | 0.00 Cr | 28.06 Cr | -12.61 Cr | -14.35 Cr | -5.59 | 8.21 Cr | -0.0795 |
| 2023-03-31 | 139.96 Cr | 108.89 Cr | 31.07 Cr | 0.2220 | 0.06 Cr | 20.15 Cr | -3.83 Cr | -5.77 Cr | -2.29 | 9.80 Cr | -0.0412 |
| 2022-03-31 | 131.19 Cr | 89.31 Cr | 41.89 Cr | 0.3193 | 0.06 Cr | 8.12 Cr | 11.20 Cr | 8.91 Cr | 3.58 | 16.43 Cr | 0.0679 |
| 2021-03-31 | 106.79 Cr | 87.48 Cr | 19.31 Cr | 0.1809 | 0.02 Cr | 6.87 Cr | -2.13 Cr | -0.21 Cr | -0.09 | 2.86 Cr | -0.0020 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.13 Cr | 439.14 Cr | 211.99 Cr | 223.6848 Cr | 139.60 Cr | 137.47 Cr | 105.68 Cr | 186.95 Cr | 0.00 Cr | 0.00 Cr | 54.46 Cr | 100.6138 Cr |
| 2024-03-31 | 1.00 Cr | 228.33 Cr | 138.35 Cr | 89.9766 Cr | 95.28 Cr | 94.28 Cr | 53.77 Cr | 103.43 Cr | 0.00 Cr | 0.00 Cr | 4.70 Cr | 73.6845 Cr |
| 2023-03-31 | 0.09 Cr | 158.11 Cr | 77.76 Cr | 80.3567 Cr | 45.12 Cr | 45.03 Cr | 41.79 Cr | 60.89 Cr | 0.00 Cr | 0.00 Cr | 7.53 Cr | 40.5158 Cr |
| 2022-03-31 | 0.04 Cr | 139.09 Cr | 49.47 Cr | 89.6268 Cr | 14.90 Cr | 14.86 Cr | 28.95 Cr | 23.63 Cr | 0.00 Cr | 0.00 Cr | 32.84 Cr | 35.9608 Cr |
| 2021-03-31 | 0.02 Cr | 85.47 Cr | 19.17 Cr | 66.2969 Cr | 0.00 Cr | -0.02 Cr | 28.18 Cr | 7.55 Cr | 0.00 Cr | 0.00 Cr | 9.83 Cr | 18.2277 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -48.9472 Cr | -95.6203 Cr | 147.1808 Cr | -95.9421 Cr | 2.6144 Cr | 3.6191 Cr | -45.9778 Cr | -57.6443 Cr | -9.0724 Cr | -2.7408 Cr | -51.9177 Cr |
| 2024-03-31 | -5.9842 Cr | -12.9028 Cr | 18.7763 Cr | -22.6944 Cr | -0.1103 Cr | 1.0047 Cr | -16.7102 Cr | -14.3479 Cr | 9.7767 Cr | -2.5847 Cr | -11.9780 Cr |
| 2023-03-31 | -2.0061 Cr | 14.7035 Cr | -13.8814 Cr | -14.5053 Cr | -1.1841 Cr | 1.1150 Cr | -12.4992 Cr | -4.6910 Cr | -1.7200 Cr | -3.7740 Cr | -12.8413 Cr |
| 2022-03-31 | 13.3320 Cr | -26.6520 Cr | 14.2733 Cr | 10.0840 Cr | 0.9528 Cr | 2.2991 Cr | -3.2480 Cr | 12.4348 Cr | -1.1402 Cr | -2.5160 Cr | -0.7712 Cr |
| 2021-03-31 | -0.8896 Cr | 3.8205 Cr | -2.4190 Cr | -2.8178 Cr | 0.5114 Cr | 1.3463 Cr | -1.9282 Cr | -0.3654 Cr | 0.0506 Cr | -2.4560 Cr | -2.8419 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 103.58 Cr | 45.13 Cr | 58.45 Cr | 0.5643 | -10.72 Cr | -14.32 Cr | -4.92 | 4.83 Cr | -0.1382 |
| 2025-03-31 | 97.27 Cr | 47.87 Cr | 49.40 Cr | 0.5078 | -11.85 Cr | -12.89 Cr | -4.69 | 3.47 Cr | -0.1325 |
| 2024-12-31 | 72.12 Cr | 31.83 Cr | 40.29 Cr | 0.5586 | -17.42 Cr | -18.68 Cr | -6.80 | -5.56 Cr | -0.2590 |
| 2024-09-30 | 67.28 Cr | 31.26 Cr | 36.02 Cr | 0.5354 | -10.38 Cr | -12.10 Cr | -4.57 | -0.33 Cr | -0.1799 |
| 2024-06-30 | 56.30 Cr | 26.34 Cr | 29.96 Cr | 0.5321 | -9.28 Cr | -12.72 Cr | -4.80 | -1.24 Cr | -0.2260 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.13 Cr | 1.49 Cr | 3.62 Cr | 57.49 Cr | 105.68 Cr | 184.16 Cr | 186.95 Cr | 439.14 Cr | 211.99 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 2.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -162.46 Cr |
| 2024-09-30 | 1.57 Cr | 0.75 Cr | 2.32 Cr | 43.30 Cr | 64.68 Cr | 124.40 Cr | 137.91 Cr | 316.68 Cr | 154.22 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 1.00 Cr | 0.00 Cr | 0.00 Cr | 1.00 Cr | 0.00 Cr | 0.00 Cr | -89.98 Cr |
| 2024-03-31 | 1.00 Cr | 0.00 Cr | 1.00 Cr | 27.24 Cr | 53.77 Cr | 111.62 Cr | 103.43 Cr | 228.33 Cr | 138.35 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -18.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -12.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -12.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -6.92 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -2.94 Cr | 10.16 Cr | 0.00 Cr | 0.00 Cr | 10.16 Cr | 11.97 Cr | 1.81 Cr | 0.00 Cr | 10.16 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2019-07-25 | July 25, 19 | 7:5 |
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹359.50 | ₹480,637,120,000.00 | ₹1,022,580.00 |
| Syngene International Limited | SYNGENE | ₹667.40 | ₹267,870,930,256.00 | ₹196,956.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹192.75 | ₹256,212,590,550.00 | ₹2,776,948.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,767.60 | ₹184,919,595,120.00 | ₹188,946.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹775.35 | ₹134,496,413,397.00 | ₹242,236.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹717.05 | ₹114,212,441,050.00 | ₹143,014.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹689.55 | ₹55,496,914,740.00 | ₹82,197.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹268.15 | ₹42,041,361,450.00 | ₹62,573.00 |
| Zota Health Care Limited | ZOTA | ₹1,269.70 | ₹38,227,365,780.00 | ₹33,784.00 |
Key Executives
Gender: male
Year Born: 1973
Gender: male
Year Born: 1975
Gender: Not Specified
Year Born: 1976
Gender: male
Year Born: 1976
Gender: male
Year Born: 1990
Gender: male
Year Born: 1984
Gender: male
Year Born: 1974
Gender: male
Year Born: 1991
FAQs about Zota Health Care Limited
The CEO is Sujit Paul.
The current price is ₹1,269.70.
The range is ₹535-1397.3.
The market capitalization is ₹3,822.74 crores.
The dividend yield is 0.08%.
The P/E ratio is -63.71.
The company operates in the Healthcare sector.
Overview of Zota Health Care Limited (ISIN: INE358U01012) is a leading Biotechnology in India. With a market capitalization of ₹3,822.74 crores and an average daily volume of 106,318 shares, it operates in the Biotechnology. The company last declared a dividend of ₹1.